Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .

Clinical trial NCT04234620 · UNKNOWN

Trial details

NCT number: NCT04234620
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Melanoma Lung Cance Breast Cancer

Start date: 2020-02-15
Primary completion: 2023-02-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.